Double Strand Break Free Genome Editing to Target Hematopoietic Stem and Progenitor Cells: Therapeutic Applicability in Fanconi Anemia

被引:0
|
作者
Ugalde, Laura [1 ]
Karasu, Erman [2 ]
Siegner, Sebastian [2 ]
Garcia, Laura [1 ]
Clemens, Alexandra [2 ]
Olalla, Beatriz [1 ]
Alvarez, Lara [1 ]
Pena, Irene [1 ]
Bueren, Juan A. [1 ]
Corn, Jacob [1 ]
Rio, Paula [1 ]
机构
[1] CIEMAT CIBERER IIS FJD, Hematopoiet Innovat Therapies Div, Madrid, Spain
[2] Swiss Fed Inst Technol, Mol Hlth Sci, Zurich, Switzerland
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
8
引用
收藏
页码:4 / 5
页数:2
相关论文
共 50 条
  • [21] Modelling Congenital Dyserythropoietic Anemia Type II through Gene Editing in Hematopoietic Stem and Progenitor Cells
    Dessy-Rodriguez, Mercedes
    Fananas-Baquero, Sara
    Venturi, Veronica
    Payan-Pernia, Salvador
    Tornador, Cristian
    Hernandez, Gonzalo
    Sanchez, Mayka
    Segovia, Jose C.
    Bustamante, Oscar Quintana
    BLOOD, 2020, 136
  • [22] Gene Editing for Congenital Dyserythropoietic Anemia Type II Model in Human Hematopoietic Stem and Progenitor Cells
    Dessy-Rodriguez, Mercedes
    Fananas-Baquero, Sara
    Venturi, Veronica
    Payan, Salvador
    Tornador, Cristian
    Hernandez, Gonzalo
    Sanchez Fernandez, Mayka
    Bueren, Juan A.
    Carlos Segovia, Jose
    Quintana-Bustamante, Oscar
    MOLECULAR THERAPY, 2021, 29 (04) : 341 - 341
  • [23] Development of a DNA double-strand break-free base editing tool in Corynebacterium glutamicum for genome editing and metabolic engineering
    Deng, Chen
    Lv, Xueqin
    Li, Jianghua
    Liu, Yanfeng
    Du, Guocheng
    Liu, Long
    METABOLIC ENGINEERING COMMUNICATIONS, 2020, 11
  • [24] Culture-free gene editing of hematopoietic stem and progenitor cells for the gene therapy of β-hemoglobinopathies
    Venkatesan, V.
    Babu, P.
    Azhagiri, M. K. K.
    Thangavel, S.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A295 - A295
  • [25] A Novel Gene Therapy Approach of Fanconi Anemia Hematopoietic Stem Cells Based on NHEJ-Mediated Gene Editing
    Roman-Rodriguez, Francisco J.
    Diez, Begona
    Alvarez, Lara
    Torres-Ruiz, Raul
    Corton, Marta
    Diaz de Heredia, Cristina
    Sevilla, Julian
    Ayuso, Carmen
    Bueren, Juan A.
    Rio, Paula
    MOLECULAR THERAPY, 2017, 25 (05) : 79 - 79
  • [26] Correction of the Energetic Defects in Pyruvate Kinase Deficiency through Genome Editing in Hematopoietic Stem and Progenitor Cells
    Fananas-Baquero, Sara
    Bustamante, Oscar Quintana
    Dever, Daniel P.
    Alberquilla, Omaira
    Sanchez-Dominguez, Rebeca
    Camarena, Joab
    Turk, Rolf
    Lorenzo, Jose Luis Lopez
    Bianchi, Paola
    Behlke, Mark
    Bueren, Juan A.
    Porteus, Matt
    Segovia, Jose C.
    BLOOD, 2020, 136
  • [27] TGF-β Pathway Inhibition Rescues the Function of Hematopoietic Stem and Progenitor Cells Derived from Patients with Fanconi Anemia
    Zhang, Haojian
    Kozono, David
    O'Connor, Kevin
    Rousseau, Alix
    Moreau, Lisa
    Gaudiano, Emily
    Greenberger, Joel S.
    Bagby, Grover C., Jr.
    Soulier, Jean
    Grompe, Markus
    Parmar, Kalindi
    D'Andrea, Alan D.
    BLOOD, 2015, 126 (23)
  • [28] mTOR Regulates DNA Damage Response of Hematopoietic Stem and Progenitor Cells Through Modulation of Fanconi Anemia Core Complex
    Guo, Fukun
    Li, Jie
    Du, Wei
    Zhang, Shuangmin
    Liu, Wei
    Thomas, George
    Kozma, Sara
    Pang, Qishen
    Zheng, Yi
    BLOOD, 2011, 118 (21) : 394 - 394
  • [29] Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control
    Li, XX
    Plett, PA
    Yang, YZ
    Hong, P
    Freie, B
    Srour, EF
    Orschell, CM
    Clapp, DW
    Haneline, LS
    BLOOD, 2003, 102 (06) : 2081 - 2084
  • [30] Modelling Congenital Dyserythropoietic Anemia Type II in Human Hematopoietic Stem and Progenitor Cells using Gene Editing
    Dessy-Rodriguez, M.
    Fananas-Baquero, S.
    Venturi, V.
    Payan, S.
    Tornador, C.
    Hernandez, G.
    Sanchez-Fernandez, M.
    Segovia, J. C.
    Quintana-Bustamante, O.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A62 - A62